Thus, ERK5 activation through WNK1 and MAP3K2 promoted prostate tumour growth and metastasis43 as well as proliferation of human chronic myeloid leukaemia cells.44 Here, WNK1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.